Delivery Order SPE2DB20D3101-SPE2DB23FRUA7
Award Date
8/7/23
Potential Completion Date
8/8/23
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,734.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rytary ER 23.75 mg-95 mg capsules, a medication used to treat Parkinson's disease. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. This award is not associated with a set-aside program and is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,115.93, is for the delivery of RYTARY ER 61.25 MG-245 MG capsules, a medication used for the treatment of Parkinson's disease. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $9,452.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used in the treatment of Parkinson's disease. The contract has an ultimate completion date of October 31, 2023 and is structured as a firm fixed price delivery order. There was no set-aside requirement for this award. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,194.28, is for the delivery of RYTARY ER (extended-release) capsules, which are used to treat Parkinson's disease. This is a firm fixed-price delivery order contract with a completion date of May 8, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $2,489.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a medication used in the treatment of Parkinson's disease. The award is a Firm Fixed Price Delivery Order with a period of performance through July 5, 2024. It is not associated with any set-aside requirements....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,237.14, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used in the treatment of Parkinson's disease. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is not associated with a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,313.68 firm fixed price delivery order is for the supply of RYTARY ER 23.75 MG-95 MG capsules, a medication used to treat Parkinson's disease. The contract has a completion date of November 13, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $3,220.38 firm fixed price contract is for the delivery of Rytary ER 48.75 mg-195 mg capsules, a specialty medication used to treat Parkinson's disease. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,049.83 firm-fixed-price delivery order is for the supply of RYTARY ER 36.25 MG-145 MG capsules, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of April 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $11,748.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication. The award is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...